Vinpocetine Market 2022 Industry Research, Segmentation, Key Players Analysis and Forecast to 2028

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7302

Gains Upheld by Consumer Inclination towards Staying ‘Mentally Sharp’

As consumers are becoming increasingly aware of connection with balanced diet and mental health, demand for dietary supplements is on the rise. This, in turn, is projected to influence the growth of vinpocetine market. The role of vinpocetine in neuroprotection and reducing neural inflammation is supported by several studies including a prospective analytical study conducted in the University of Benin Teaching Hospital, Nigeria. However, amount of scientific evidence on the efficacy of vinpocetine against cognitive decline is relatively less as compared to other drugs tested for this purpose.

Today, while increasing number of geriatric population intent to stay mentally sharp, millennials are looking for ways to manage hectic schedule and stressful lifestyles. To that end, the dietary supplement industry in general and the vinpocetine market in particular are selling the benefits of healthier, longer life. Subsequently, consumers are buying the idea that these supplements and other nutritional products can help fulfil their needs. The result is expected to lead to increased demand for vinpocetine in near future. The vinpocetine market is further expected to benefit from growing consumer preference for multi-nutritional supplements to enhance their health status. With cognition being one of the most important public health concerns, a number of dietary supplements containing vinpocetine are being introduced to offer diverse cognitive benefits. However, it is pertinent to note that, no clinical research suggests that vinpocetine protects against slow aging of brain or dementia, while it failed to improve cognition in Alzheimer’s patients.

Recent FDA Action on Dietary Supplements Containing Vinpocetine to Impede Market Growth

The demand for various dietary supplements such as calcium supplements and fiber supplements continues to move on an upward swing. However, the use of vinpocetine in dietary supplements, especially in the U.S., has come under intense scrutiny, on the account lack of clinical evidence to prove its benefits, undefined dosage parameters, and risks to human health. Vinpocetine has been widely sold in the country as a dietary supplement for about two decades. It is considered a pharmaceutical available by prescription to treat cognitive impairment in several European countries, China, and Japan.

In September 2016, the FDA had ruled that vinpocetine does not fulfil the definition of a dietary ingredient, and is prohibited from being marketed as a dietary supplement under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Additionally, in June 2019, the federal agency issued a warning advising pregnant women and those of childbearing age to avoid dietary supplements containing vinpocetine, as these products could cause miscarriage and issues with fetal development. These factors are expected to represent as a potential threat to sales of vinpocetine. Further, the sale of this ingredient is banned in Canada and in Oceanian countries such as Australia and New Zealand, thereby negatively impacting the global market growth.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-7302

Vinpocentine Market Players to Prioritize Scientific Research

The vinpocetine market is currently operated by a few number of players including Source Naturals, Naturetition Supplements, Puritan’s Pride, Jarrow Formulas, Life Extension, We like Vitamins, Pure Encapsulations, Absorb Health, and Swanson Superior Herbs. As dietary supplements continue to play an active part of the diet regimen in modern lifestyle, the demand for vinpocetine is expected to grow in near future. Although vinpocetine is not approved in the United States as a pharmaceutical, it is widely available as a supplement with reports stating the benefits for dementia patients. In addition, after over two decades of extensive use across Europe and Asia, side effects are rarely reported among consumers taking supplements containing vinpocetine, which is likely to influence in its demand. Despite recent claims regarding the adverse effects of vinpocetine, it remains widely available as a dietary supplement – often marketed as nootropics that are taken to improve cognitive function. As the FDA leaves in doubt the future regulatory status of vinpocetine, manufacturers are focusing on demonstrating quality and efficacy of their products through notable scientific research. However, as consumers are continually looking for product transparency and natural alternatives to conventional drugs or dietary supplements, key market players will need to redefine their growth and marketing strategies to maintain their position in the vinpocetine market.

Key Data Points Covered in the Report

Some of the key data points covered in our report include:

• An overview of the market, including background and evolution
• Macroeconomic factors affecting the market and its potential
• Market dynamics, such as drivers, challenges, and trends
• Detailed value chain analysis of the market
• The cost structure of the products and segments covered in the study

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/7302